XML 12 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2024
Dec. 31, 2023
Current Assets:    
Cash and cash equivalents $ 2,252,247 $ 884,377
Investments held in marketable securities 12,428,218 10,181,618
Accounts receivable 27,400 19,300
Prepaid expenses and other current assets 295,861 305,231
Total Current Assets 15,003,726 11,390,526
Property and equipment, net 345,807 356,055
Right-of-use assets 78,146 151,447
Intangible assets, net 668,818 713,692
Deferred offering costs 22,381
Total Assets 16,118,878 12,611,720
Current Liabilities:    
Accounts payable 215,920 189,389
Accrued expenses and other current liabilities 447,622 711,686
Deferred revenue 80,700
Lease liability 83,580 162,317
Derivative liabilities 4,491,969 1,543,953
Total Current Liabilities 5,319,791 2,607,345
Total Liabilities 5,319,791 2,607,345
Commitments and contingencies
Stockholders’ Equity:    
Preferred stock, $0.01 par value; 20,000,000 shares authorized; Series B Convertible Preferred Stock; 1,543,158 shares designated, 1,398,158 shares issued and outstanding at June 30, 2024 and December 31, 2023 13,982 13,982
Common stock, $0.0001 par value; 75,000,000 shares authorized; 6,919,919 and 4,706,917 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 692 471
Additional paid-in capital 163,735,564 156,689,256
Accumulated deficit (152,951,151) (146,699,334)
Total Stockholders’ Equity 10,799,087 10,004,375
Total Liabilities and Stockholders’ Equity $ 16,118,878 $ 12,611,720